Literature DB >> 11916183

Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid.

N S Silverman1, M Morgan, W S Nichols.   

Abstract

Increasing use of short-course antifungal therapies in patients with recurrent vulvovaginitis may enable the emergence of less-common, more resistant yeast strains as vaginal pathogens. We report the case of a patient with chronically symptomatic and repeatedly treated vaginal candidiasis whose infection was attributable to Candida lusitaniae, a previously unreported cause of candidal vaginitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11916183      PMCID: PMC1784662          DOI: 10.1155/S1064744901000400

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  11 in total

1.  Vulvovaginitis. When Candida becomes a problem.

Authors:  J D Sobel
Journal:  Dermatol Clin       Date:  1998-10       Impact factor: 3.478

2.  Boric acid treatment of vulvovaginal candidiasis.

Authors:  T E Swate; J C Weed
Journal:  Obstet Gynecol       Date:  1974-06       Impact factor: 7.661

3.  Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.

Authors:  J D Sobel; W Chaim
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

4.  Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.

Authors:  A Minari; R Hachem; I Raad
Journal:  Clin Infect Dis       Date:  2000-12-28       Impact factor: 9.079

5.  Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.

Authors:  J D Sobel
Journal:  N Engl J Med       Date:  1986-12-04       Impact factor: 91.245

6.  Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata.

Authors:  D Kerridge; R O Nicholas
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

7.  Development of resistance to amphotericin B in Candida lusitaniae infecting a human.

Authors:  D Pappagianis; M S Collins; R Hector; J Remington
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.

Authors:  F Meunier-Carpentier; T E Kiehn; D Armstrong
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

9.  Epidemiology of vaginal Candida infection: significance of numbers of vaginal yeasts and their biotypes.

Authors:  F C Odds; C E Webster; V C Riley; P G Fisk
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-05       Impact factor: 2.435

Review 10.  Emergence of a new opportunistic pathogen, Candida lusitaniae.

Authors:  R J Blinkhorn; D Adelstein; P J Spagnuolo
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  2 in total

1.  Usefulness of McRAPD for typing and importance of biofilm production in a case of nosocomial ventriculoperitoneal shunt infection caused by Candida lusitaniae.

Authors:  Petr Hamal; Juraj Hanzen; Frantisek Horn; Jitka Trtkova; Lenka Ruskova; Renata Vecerova; Filip Ruzicka; Anna Vollekova; Vladislav Raclavsky
Journal:  Folia Microbiol (Praha)       Date:  2011-09-06       Impact factor: 2.099

2.  Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae.

Authors:  Seyed Ebrahim Hashemi; Tahereh Shokohi; Mahdi Abastabar; Narges Aslani; Mahbobeh Ghadamzadeh; Iman Haghani
Journal:  Curr Med Mycol       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.